AN2 Therapeutics, Inc. (NasdaqGS: ANTX)
Health Care · Pharmaceuticals · US
$5.63
-3.10% today · +416.4% 1Y
AN2 Therapeutics, Inc. (NasdaqGS: ANTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $219.25M and employs 21 people.
Over the last twelve months the share price has gained 416.4%, trading between 1.00 and 7.19.
Tweenvest scores AN2 Therapeutics, Inc. across four factors: quality 26/100. Its strongest factor is quality.
ANTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $219.25M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.04
- Dividend yield
- —
- Beta (5Y)
- -0.99
- 52-week high
- $7.19
- 52-week low
- $1.00
- Avg volume (3M)
- —
- Shares outstanding
- 37.74M
- Employees
- 21
- Next earnings
- —
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.
- ISIN
- US0373261058
- Founded
- 2017
- Listed since
- Mar 25, 2022
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.